Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
65.46
-2.01 (-2.98%)
At close: Oct 17, 2025, 4:00 PM EDT
65.72
+0.26 (0.40%)
After-hours: Oct 17, 2025, 7:44 PM EDT
Guardant Health Stock Forecast
Stock Price Forecast
The 22 analysts that cover Guardant Health stock have a consensus rating of "Strong Buy" and an average price target of $64.91, which forecasts a -0.84% decrease in the stock price over the next year. The lowest target is $35 and the highest is $80.
Price Target: $64.91 (-0.84%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 8 | 8 | 7 | 7 |
| Buy | 10 | 10 | 10 | 10 | 14 | 15 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 20 | 18 | 18 | 21 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $68 | Buy | Maintains | $60 → $68 | +3.88% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $70 | Buy | Maintains | $60 → $70 | +6.94% | Oct 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 → $75 | Strong Buy | Maintains | $65 → $75 | +14.57% | Sep 26, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $63 → $72 | Strong Buy | Maintains | $63 → $72 | +9.99% | Sep 25, 2025 |
| Stifel | Stifel | Strong Buy Maintains $60 → $70 | Strong Buy | Maintains | $60 → $70 | +6.94% | Sep 25, 2025 |
Financial Forecast
Revenue This Year
948.14M
from 739.02M
Increased by 28.30%
Revenue Next Year
1.17B
from 948.14M
Increased by 22.98%
EPS This Year
-3.17
from -3.56
EPS Next Year
-2.58
from -3.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 975.0M | 1.3B | |||
| Avg | 948.1M | 1.2B | |||
| Low | 867.3M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.9% | 32.5% | |||
| Avg | 28.3% | 23.0% | |||
| Low | 17.4% | 9.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.77 | -1.24 | |||
| Avg | -3.17 | -2.58 | |||
| Low | -3.19 | -3.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.